Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-011293
Filing Date
2021-11-08
Accepted
2021-11-08 17:00:21
Documents
1
Period of Report
2021-11-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-54176.html 4  
1 PRIMARY DOCUMENT marketforms-54176.xml 4 11671
  Complete submission text file 0001214659-21-011293.txt   13069
Mailing Address 15641 RED HILL AVENUE, SUITE 200 TUSTIN CA 92780
Business Address
AULT MILTON C III (Reporting) CIK: 0001212502 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-40483 | Film No.: 211388750

Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Issuer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations